COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 10 pc

7680704030027 Pharmacode 1132606 CH-70403 J07BN01 08.08.
COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 10 pc
Fiches Amavita / Sun Store / Coop Vitality

Details

GTIN
7680704030027
Pharmacode
1132606
Product number
7040301
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
Suspension: COVID-19 mRNA LP.8.1 30 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, 1 ml corresp..

Articles (1)

Comirnaty LP.8.1 30 Mikrogramm, Injektionsdispersion in einer Fertigspritze
Mikrogramm
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/02/2026
Patient information leaflet
Français
28/02/2026
Patient information leaflet
Italien
28/02/2026
Professional SmPC
Allemand
28/02/2026
Professional SmPC
Français
28/02/2026
Professional SmPC
Italien
28/02/2026

Detailed composition

Substance Quantity Type Category
COVID-19 mRNA LP.8.1
30.0 UG Substance Wirkstoff (Principe actif)
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas)
- Substance HNIDK
2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum
- Substance HNIDK
1,2-distearoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
cholesterolum
- Substance HNIDK
saccharum
- Substance HNIDK
trometamolum
- Substance HNIDK
trometamoli hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
70403
Drug name
Comirnaty LP.8.1, Injektionsdispersion in einer Fertigspritze
Galenic form
INLFS
ATC Code
J07BN01
Authorization status
Z
Dispensation category
B
First authorization
06/08/2025
Authorization expiration date
05/08/2030
IT number
08.08.
Domain
Human medicine
Field of application
Comirnaty LP.8.1 (30 Mikrogramm)/Dosis gebrauchsfertige Injektionsdispersion ist indiziert für die aktive Immunisierung zur Vorbeugung der durch das SARS-CoV-2-Virus hervorgerufenen COVID-19-Erkrankung bei Personen ab 12 Jahren.

Packaging details

Description (FR)
COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 10 pc
Description (DE)
COMIRNATY LP.8.1 30 Mikrogramm Inj Lös 30 µg 10 St
Market launch
06/08/2025
Narcotic (BTM)
No

Other packaging sizes

COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 1 pce
1 FESP
View
Buy us a coffee Explore the data